The Westaim Corporation
Medical Devices & Tech
144 - 4th Ave. Southwest Suite 1010
Calgary, Alberta T2P 3N4 Canada
phone: (403) 237-7272
fax: (403) 237-6565
Symbol WED
Exchange TSX
Founded 0
Employees 240
www.westaim.com
Research Sector Medical Devices & Tech
Summary Description
Wound care and pharmaceutical products based on nanotechnology.
Management
Barry M. Heck, President and Chief Executive Officer; G.A. (Drew) Fitch, Senior Vice President and Chief Financial Officer; Anthony B. Johnston, Senior Vice President; Brian D. Heck, Vice President, General Counsel and Corporate Secretary; Nicolas W. Khoury, President; NUCRYST Pharmaceuticals Corp.; Scott H. Gillis, President and Chief Executive Officer
Ownership
Financials


* numbers in thousands

 
Keywords
woundwound, woundcare

Comment | Printable Version | Aug. 01, 2008
If you work for The Westaim Corporation and want to update this profile, click here

Description
Westaim invests in high-potential businesses targeting large commercial markets. Its currently owns two technology businesses, iFire Technology and NUCRYST Pharmaceuticals. NUCRYST Pharmaceuticals researches, develops and commercializes wound care and pharmaceutical products based on its noble metal nanotechnology.
Products / Services
NUCRYST's wound care products, Acticoat dressings with SILCRYST Nanocrystals, are designed for serious wounds, including burns and chronic wounds.
Market / Customers
NUCRYST's SILCRYST nanocrystals are marketed, sold and distributed globally by Smith & Nephew. Acticoat dressings are sold in 30 countries.
Status
NUCRYST's first dermatology drug, NPI 32101, is based on its platform nanocrystalline silver technology.


2008-08-28-899